Share&Service announced on the 26th that EasyBreath, a respiratory rehabilitation software being developed as a digital therapeutic device (DTx), has been designated as an innovative medical device.
Share&Service's respiratory rehabilitation digital therapeutic device EasyBreed Photo by Busan Union Technology Holdings
EasyBreath is software that provides personalized respiratory rehabilitation treatment for patients who need respiratory rehabilitation. It is the first item in Korea to be designated as an innovative medical device.
Respiratory rehabilitation treatment is a therapy whose efficacy and safety have been proven worldwide in patients with lung diseases. However, only some secondary and tertiary medical institutions have properly equipped respiratory rehabilitation programs, accounting for about 25% of all hospitals.
On the other hand, there are 3.3 million patients with chronic obstructive pulmonary disease (COPD) in Korea alone, and it is known that there are 380 million patients worldwide. When including related diseases such as asthma, lung cancer, and pneumonia, the number of patients in Korea is estimated to exceed 5 million.
The company explained that respiratory rehabilitation DTx will improve exercise capacity and reduce dyspnea symptoms in chronic lung disease patients who have high prevalence and mortality rates. Through this, it is expected to overcome the limitations of the existing domestic respiratory rehabilitation system and conditions, provide essential treatment to more patients, reduce emergency room visits and readmissions of chronic lung disease patients, and contribute to stabilizing national healthcare finances.
Once EasyBreath receives product approval from the Ministry of Food and Drug Safety, it is expected to be prescribed in actual clinical settings through the establishment of reimbursement fees. Share&Service is also conducting the first confirmed clinical trial for cardiac rehabilitation DTx in Korea, approved by the Ministry of Food and Drug Safety.
Choi Hee-eun, CEO of Share&Service, said, "After the approval of the respiratory rehabilitation software EasyBreath, we will promptly commercialize it domestically to ensure that more lung disease patients can receive respiratory rehabilitation treatment in their daily lives."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
